Cervical cancer as the leading cause of mortality of cancer in women is divided into two categories including "early stage" and advanced stage. Open radical hysterectomy with lymph node dissection has been introduced as the first choice of treatment for early stages of cervical cancer in women. However, this type of surgery is accompanied with some significant complications such as bladder dysfunction, blood loss, and transfusion-related complications which may in part be explained by its invasive procedure and lengthy duration of operation. On the other hand, laparoscopic surgery in cervical cancer has recently been established as a non-invasive procedure with fewer complications such as shorter hospital stay, better cosmetic, faster recov...
Despite the lack of conclusive evidence supporting this treatment modality, neoadjuvant chemotherapy...
We report the use of radical vaginal trachelectomy (RVT) with pelvic laparoscopic lymphadenectomy (L...
Despite the lack of conclusive evidence supporting this treatment modality, neoadjuvant chemotherapy...
Jianfeng Guo,* Lu Yang,* Jing Cai, Linjuan Xu, Jie Min, Yi Shen, Zhoufang Xiong, Weihong Dong, Vichi...
Abstract Background Since the release of the LACC trial results in 2018, the safety of laparoscopic ...
Surgery is the mainstay of treatment in the management of early-stage cervical cancer. Until the pub...
Surgery is the mainstay of treatment in the management of early-stage cervical cancer. Until the pub...
Cervical carcinoma is the second most common cancer in women, particularly from the developing count...
Endometrial cancer is the most common carcinoma of the female genital organs and cervical cancer is ...
Background: Recent evidence indicates that some minimally invasive surgery approaches, such as lapar...
Objective: To communicate a minimally invasive technique for surgical handling of early-stage cervic...
Radical hysterectomy and plus pelvic node dissection are the primary methods of treatment for patien...
Cervical cancer is the third most common female cancer worldwide. Radical hysterectomy with lymph no...
SummaryCervical cancer is one of the most common malignancies of the female lower genital tract. The...
BackgroundThis meta-analysis comprehensively compared intraoperative and postoperative complications...
Despite the lack of conclusive evidence supporting this treatment modality, neoadjuvant chemotherapy...
We report the use of radical vaginal trachelectomy (RVT) with pelvic laparoscopic lymphadenectomy (L...
Despite the lack of conclusive evidence supporting this treatment modality, neoadjuvant chemotherapy...
Jianfeng Guo,* Lu Yang,* Jing Cai, Linjuan Xu, Jie Min, Yi Shen, Zhoufang Xiong, Weihong Dong, Vichi...
Abstract Background Since the release of the LACC trial results in 2018, the safety of laparoscopic ...
Surgery is the mainstay of treatment in the management of early-stage cervical cancer. Until the pub...
Surgery is the mainstay of treatment in the management of early-stage cervical cancer. Until the pub...
Cervical carcinoma is the second most common cancer in women, particularly from the developing count...
Endometrial cancer is the most common carcinoma of the female genital organs and cervical cancer is ...
Background: Recent evidence indicates that some minimally invasive surgery approaches, such as lapar...
Objective: To communicate a minimally invasive technique for surgical handling of early-stage cervic...
Radical hysterectomy and plus pelvic node dissection are the primary methods of treatment for patien...
Cervical cancer is the third most common female cancer worldwide. Radical hysterectomy with lymph no...
SummaryCervical cancer is one of the most common malignancies of the female lower genital tract. The...
BackgroundThis meta-analysis comprehensively compared intraoperative and postoperative complications...
Despite the lack of conclusive evidence supporting this treatment modality, neoadjuvant chemotherapy...
We report the use of radical vaginal trachelectomy (RVT) with pelvic laparoscopic lymphadenectomy (L...
Despite the lack of conclusive evidence supporting this treatment modality, neoadjuvant chemotherapy...